These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6132854)

  • 1. Pharmacological studies on the noradrenergic control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1983 Mar; 49(3):358-63. PubMed ID: 6132854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine involvement in the control of growth hormone secretion in the domestic fowl.
    Buonomo FC; Zimmermann NG; Lauterio TJ; Scanes CG
    Gen Comp Endocrinol; 1984 Jun; 54(3):360-71. PubMed ID: 6735152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic growth hormone secretion in the domestic fowl (Gallus domesticus): alpha adrenergic regulation.
    Buonomo FC; Lauterio TJ; Scanes CG
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(2):409-13. PubMed ID: 6149089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of central catecholaminergic mechanisms in mediating the preovulatory surge of luteinizing hormone in the domestic hen.
    Knight PG; Wilson SC; Gladwell RT; Cunningham FJ
    J Endocrinol; 1982 Aug; 94(2):295-304. PubMed ID: 6125554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release.
    Martín AI; Fernández-Ruiz J; López-Calderón A
    J Endocrinol; 1995 Mar; 144(3):511-5. PubMed ID: 7738475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic involvement in the estrogen-induced suppression of frequency of pulsatile luteinizing hormone secretion in the ovariectomized rat.
    Tadokoro Y; Akema T; Kimura F
    Brain Res; 1986 Aug; 380(1):69-75. PubMed ID: 3019466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for hypothalamic noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release.
    Van Vugt DA; Aylsworth CF; Sylvester PW; Leung FC; Meites J
    Neuroendocrinology; 1981 Nov; 33(5):261-4. PubMed ID: 7301047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resumption with clonidine of pulsatile LH release following acute norepinephrine depletion in ovariectomized rats.
    Estes KS; Simpkins JW; Kalra SP
    Neuroendocrinology; 1982; 35(1):56-62. PubMed ID: 6287329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhibitors of catecholamine synthesis on the pituitary response to LH-RH.
    Rettori V; Seilicovich A; Goijman S; Debeljuk L
    Arch Androl; 1981 Mar; 6(2):151-4. PubMed ID: 6113817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats.
    Thompson MA; Woolley DE; Gietzen DW; Conway S
    Endocrinology; 1983 Sep; 113(3):855-65. PubMed ID: 6135604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by catecholaminergic blockers of the neurotensin-induced enhancement of luteinizing hormone secretion in the ovariectomized estrogen-primed rat.
    Akema T; Kimura F
    Neuroendocrinology; 1989 Dec; 50(6):688-92. PubMed ID: 2559343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of catecholaminergic and cholinergic mechanisms in the pulsatile release of LH in the long-term ovariectomized rat.
    Gnodde HP; Schuiling GA
    Neuroendocrinology; 1976; 20(3):212-23. PubMed ID: 8741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminergic involvement in the control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Rabii J; Scanes CG
    Gen Comp Endocrinol; 1981 Oct; 45(2):162-6. PubMed ID: 6269957
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of drugs which modify catecholamine activity on amplification of LH release induced by locus coeruleus electrical stimulation.
    Gitler MS; Barraclough CA
    Brain Res; 1987 Dec; 437(2):332-8. PubMed ID: 2893654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
    Sarkar DK; Smith GC; Fink G
    Brain Res; 1981 Jun; 213(2):335-49. PubMed ID: 6113874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.